Prescription drug · BLA
Genotropin (somatropin) NDC 0013-2651
Kit · Pfizer Laboratories Div Pfizer Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0013-2651-02 | 00013265102 | 7 CARTRIDGE in 1 CARTON (0013-2651-02) / 1 KIT in 1 CARTRIDGEMarketed from Dec 20, 1995 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Genotropin
- Generic name (nonproprietary)
- somatropin
- Dosage form
- Kit
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 020280
- Marketing start
- Listing expires
- Identifiers
- Product ID 0013-2651_5aa3307a-c0bc-43c0-8177-3bb1cad66d7aSPL ID 5aa3307a-c0bc-43c0-8177-3bb1cad66d7aSPL set ID ffebf88b-d257-4542-9808-74d9b7167765RxCUI 241975, 762830, 762833, 762834, 762836, 762837, 762839, 762841, 762843, 762846, 762849, 762850, 762852, 762857, 762859, 762866, 762868, 762873, 762875, 762895, 762897, 763488, 763489, 996558, 996559
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400013265102followed by a unit qualifier and the quantityPackage 00013-2651-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
GENOTROPIN is a recombinant human growth hormone indicated for: • Pediatric: Treatment of children with growth failure due to growth hormone deficiency (GHD), Prader-Willi syndrome, Small for Gestational Age, Turner syndrome, and Idiopathic Short Stature ( 1.1 ) • Adult: Treatment of adults with either adult onset or childhood onset GHD ( 1.2 ) 1.1 Pediatric Patients GENOTROPIN is indicated for the treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone. GENOTROPIN is indicated for the treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS). The diagnosis of PWS should be confirmed by appropriate g…
Excerpt only. Read the full label for complete information.
Other NDCs under BLA 020280
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2649 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2656 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2626 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2652 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2650 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2657 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2646 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2654 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2655 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2653 |
| Genotropinsomatropin | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0013-2658 |